Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

TNFSF13 Antikörper

TNFSF13 Reaktivität: Human WB, ELISA, Inhibition Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN636631
  • Target Alle TNFSF13 Antikörper anzeigen
    TNFSF13 (Tumor Necrosis Factor (Ligand) Superfamily, Member 13 (TNFSF13))
    Reaktivität
    • 79
    • 37
    • 21
    • 10
    • 5
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    Human
    Wirt
    • 79
    • 20
    • 4
    • 2
    • 1
    • 1
    Kaninchen
    Klonalität
    • 80
    • 27
    Polyklonal
    Konjugat
    • 59
    • 18
    • 6
    • 4
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser TNFSF13 Antikörper ist unkonjugiert
    Applikation
    • 61
    • 33
    • 33
    • 32
    • 17
    • 15
    • 15
    • 14
    • 14
    • 13
    • 6
    • 6
    • 5
    • 4
    • 4
    • 2
    • 2
    Western Blotting (WB), ELISA, Blocking Antibody (Inhibition)
    Aufreinigung
    Purified
    Immunogen
    APRIL antibody was raised in rabbit using highly pure recombinant human APRIL as the immunogen.
    Top Product
    Discover our top product TNFSF13 Primärantikörper
  • Applikationshinweise
    Optimal conditions should be determined byt he investigator.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Lyophilized
    Konzentration
    Lot specific
    Buffer
    Lyophilized from PBS, pH 7.2.
    Handhabung
    Avoid repeated freeze/thaw cycles.
    Dilute only prior to immediate use.
    Lagerung
    4 °C/-20 °C
    Informationen zur Lagerung
    Store at -20 °C until reconstitution. Following reconstitution product may be stored at 4 °C in the short term. For long term storage aliquot and freeze at -20 °C.
  • Target
    TNFSF13 (Tumor Necrosis Factor (Ligand) Superfamily, Member 13 (TNFSF13))
    Andere Bezeichnung
    APRIL (TNFSF13 Produkte)
    Synonyme
    APRIL antikoerper, CD256 antikoerper, TALL-2 antikoerper, TALL2 antikoerper, TRDL-1 antikoerper, ZTNF2 antikoerper, 2310026N09Rik antikoerper, April antikoerper, Tall2 antikoerper, Trdl1 antikoerper, SLAN antikoerper, ANP32B antikoerper, april antikoerper, tnf13 antikoerper, TNLG7B antikoerper, TNF superfamily member 13 antikoerper, tumor necrosis factor (ligand) superfamily, member 13 antikoerper, acidic leucine-rich nuclear phosphoprotein 32 family member B antikoerper, TNFSF13 antikoerper, Tnfsf13 antikoerper, LOC494442 antikoerper, tnfsf13 antikoerper
    Hintergrund
    APRIL, a member of the TNF superfamily, is expressed in monocytes, macrophages, certain transformed cell lines, certain cancers of colon, and lymphoid tissues. APRIL, along with another TNF family member, BAFF, compete for two receptors, TACI and BCMA. APRIL has the ability to stimulate proliferation of various tumor cell lines including Jurkat T cells and MCF-7 carcinoma cells. Like BAFF, APRIL also stimulates the proliferation of B and T cells. The human APRIL gene codes for at least four alternatively spliced transcriptional variants, which give rise to different isoforms of the APRIL precursor protein. All isoforms can be cleaved by the protease, furin, to release a soluble C-terminal fragment, which comprises the TNF like receptor binding of the APRIL precursor.
    Molekulargewicht
    21.9 kDa (predicted detection band MW)
    Pathways
    Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response
Sie sind hier:
Kundenservice